Literature DB >> 28650911

Creatinine Clearance Estimations for Vancomycin Maintenance Dose Adjustments.

Martin Šíma1, Jan Hartinger, Irena Štenglová Netíková, Ondřej Slanař.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 28650911     DOI： 10.1097/MJT.0000000000000616

Source DB:  PubMed          Journal:  Am J Ther        ISSN： 1075-2765            Impact factor:   2.688


× No keyword cloud information.
  5 in total

1.  Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance.

Authors:  Yan-Xia Yu; Jian Lu; Hao-di Lu; Lan Li; Jing-Jing Li; Lu Shi; Lu-Fen Duan; Zhi-Wei Zhuang; Su-Dong Xue; Yi Shen; Lian Tang
Journal:  Eur J Hosp Pharm       Date:  2021-01-07

2.  Initial dosing of intermittent vancomycin in adults: estimation of dosing interval in relation to dose and renal function.

Authors:  Martin Šíma; Jan Hartinger; Tomáš Grus; Ondřej Slanař
Journal:  Eur J Hosp Pharm       Date:  2019-08-07

3.  Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement.

Authors:  Bita Shahrami; Farhad Najmeddin; Saeideh Ghaffari; Atabak Najafi; Mohammad Reza Rouini; Mojtaba Mojtahedzadeh
Journal:  Crit Care Res Pract       Date:  2020-12-24

4.  A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran.

Authors:  Parisa Ghasemiyeh; Afsaneh Vazin; Farid Zand; Amir Azadi; Iman Karimzadeh; Soliman Mohammadi-Samani
Journal:  Res Pharm Sci       Date:  2020-11-27

5.  Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients.

Authors:  Eliška Dvořáčková; Martin Šíma; Jakub Petrus; Eva Klapková; Petr Hubáček; Jiří Pozniak; Jan Havlín; Robert Lischke; Ondřej Slanař
Journal:  Pharmaceutics       Date:  2022-02-13       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.